Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin in Amyotrophic Lateral Sclerosis
NCT03359538Phase 2Completed
- Sponsor
- Azienda Ospedaliera Universitaria Policlinico
- Start
- Sep 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in amyotrophic lateral sclerosis (ALS), sponsored by Azienda Ospedaliera Universitaria Policlinico. Started Sep 2017; status: completed.
02
Drugs
sirolimus
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT03359538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03359538.